K Smigel. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adenomatous Polyposis Coli/drug therapyAnti-Inflammatory Agents, Non-Steroidal/therapeutic useAnticarcinogenic Agents/therapeutic useArthritis/drug therapyCelecoxibCyclooxygenase 2Cyclooxygenase 2 InhibitorsCyclooxygenase Inhibitors/therapeutic useDrug ApprovalHumansIsoenzymes/pharmacologyMembrane ProteinsProstaglandin-Endoperoxide Synthases/pharmacologyPyrazolesSulfonamides/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » Anti-Inflammatory Agents, Non-SteroidalAnticarcinogenic AgentsCyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsIsoenzymesMembrane ProteinsPyrazolesSulfonamidesCyclooxygenase 2PTGS2 protein, humanProstaglandin-Endoperoxide SynthasesCelecoxib
Year: 2000 PMID: 10675374 DOI: 10.1093/jnci/92.4.297
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506